Patent ID: 7166608

Claim:
A compound selected from the group consisting of: (RS)-2-(2-(4-fluoro)phenoxyethyl-1-((2-methyl-5-phenyl)thiazolyl)carbonyl)-4-trifluoroacetylpiperazine, (RS)-4-methyl-1-((4-(2-methyl-5-phenyl)thiazolyl)carbonyl)-2-(2-phenoxyethyl)piperazine, (RS)-2-(2-(4-fluoro)phenoxyethyl)-1-((4-(2-methyl-5-phenyl)thiazolyl)carbonyl)piperazine, (RS)-4-methyl-2-(2-phenoxyethyl)-1-((2-phenyl)benzamido)-piperazine, (RS)-4-(benzyloxycarbonyl)-1-((2-(3-methyl-[1,2,4]-oxadiazol-5-yl)-phenyl)carbonyl-2-(2-phenoxyethyl)piperazine, (RS)-4-(benzyloxycarbonyl)-1-((4-(2-methyl-5-phenyl)thiazolyl)carbonyl)-2-(2-phenoxyethyl)piperazine, (RS)-4-(methoxycarbonyl)-1-((2-phenyl)benzamido)-2-(2-phenoxyethyl)piperazine, (RS)-4-(methoxycarbonyl)-1-((4-(2-methyl-5-phenyl)thiazolyl)carbonyl)-2-(2-phenoxyethyl)piperazine, (RS)-4-(methoxycarbonyl )-1-((1-naphthyl)carbonyl)-2-(2-phenoxyethyl)piperazine, (RS)-4-acetyl-1-((4-(2-methyl-5-phenyl)thiazolyl)carbonyl)-2-(2-phenoxyethyl)piperazine, and (RS)-1-((2-Phenyl)benzamido)-2-(2-phenoxyethyl)piperazine acetate, or a pharmaceutically acceptable salt thereof.